Sequana Medical announced today that CMS recommended that its Alfapump system become eligible for a new incremental payment. Alfapump treats these fluid overload conditions that arise due to liver cirrhosis and malignant ascites. The fully implantable, wirelessly charged device continuously collects ascites as it forms in the abdominal cavity. It then moves into the bladder, […]
Centers for Medicare and Medicaid Services (CMS)
Abbott earns Medicare win for CardioMems
An Abbott official said on social media that the company secured a significant Medicare win for its CardioMEMS platform. Keith Boettiger, VP of Abbott’s heart failure business, posted the update on LinkedIn. He said CMS granted a new national coverage determination for CardioMEMS. “This decision is a massive step forward toward increasing access to CardioMEMS […]
Edwards Lifesciences scores a win at CMS for TTVR
The Centers for Medicare & Medicaid Services (CMS) has announced a proposed decision to cover transcatheter tricuspid valve replacement (TTVR) for Medicare beneficiaries with severe symptomatic tricuspid regurgitation. The proposed decision would allow coverage under a Coverage with Evidence Development (CED) framework, requiring the procedure to be part of a CMS-approved clinical study to ensure […]
AdvaMed weighs in on Dr. Oz’s selection to lead CMS
President-elect Donald Trump today said he is nominating Dr. Mehmet Oz to serve as administrator of the Centers for Medicare & Medicaid Services (CMS). Oz would serve under Robert F Kennedy Jr. — who Trump nominated as secretary of the U.S. Department of Health and Human Services — if Oz and Kennedy are confirmed by […]
Medtronic, Recor Medical score renal denervation reimbursement wins
Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation (RDN) technologies. Going into effect on Jan. 1, 2025, the approvals could increase patient access to the new hypertension treatments. Medtronic secured a Transitional Pass-Through (TPT) payment under the Medicare Hospital Outpatient Prospective Payment System for its Symplicity Spyral renal […]
CMS initiates coverage review for Abbott TriClip system
The Centers for Medicare & Medicaid Services (CMS) accepted a formal request to provide a national coverage analysis (NCA) for the Abbott TriClip. BTIG analysts Marie Thibault and Sam Eiber say Abbott requested the NCA for its transcatheter edge-to-edge repair system for treating tricuspid valve regurgitation (T-TEER). It falls under a pilot through the Transitional […]
Medtronic, Recor Medical earn CMS NTAP wins for renal denervation tech
Medtronic and Recor Medical earned a reimbursement win for their renal denervation (RDN) platforms with a new Final Rule from CMS. CMS posted its FY25 Inpatient Prospective Payment System (IPPS) Final Rule, which includes the New Technology Add-on Payment (NTAP) program. NTAP supports access for newly approved, innovative technologies where the cost to adopt may […]
CVRx earns Medicare win for Barostim procedure
CVRx (Nasdaq:CVRX) announced today that the Centers for Medicare and Medicaid Services (CMS) reassigned its Barostim implant procedure. CMS reassigned Barostim for the inpatient setting as part of the Fiscal Year (FY) 2025 Medicare Hospital Inpatient Prospective Payment System (IPPS) final rule. In FY 2024, CMS assigned Barostim to MS-DRGs 252, 253, 254. That had […]
Cala names new CEO, earns Medicare coverage for TAPS therapy
Cala announced today that it picked a new CEO as its TAPS therapy for essential tremor (ET) received Medicare coverage. The company promoted current Chief Product Officer Deanna Harshbarger to the corner office, effective immediately. She also becomes a member of the company’s board of directors. Renee Ryan, who became CEO at Cala in 2019, […]
Ekso Bionics earns Medicare win for exoskeleton tech
Ekso Bionics (Nasdaq:EKSO) announced that the Centers for Medicare & Medicaid Services (CMS) proposed a payment level for its exoskeleton. The Pricing, Data Analysis, and Coding (PDAC) contractor completed its review of the Ekso Indego Personal, approving the use of Healthcare Common Procedure Coding System (HCPCS) Code K1007 to bill Medicare for the device. CMS […]
CVRx scores Medicare win on outpatient Barostim payments
CVRx (Nasdaq:CVRX) announced today that the Centers for Medicare and Medicaid Services (CMS) reassigned its Barostim implant procedure. The CMS change assigns the CVRx neuromodulation implant for procedures performed in the outpatient setting. It comes as part of the 2024 Medicare Hospital Outpatient Prospective Payment System (OPPS) final rule. Barostim’s reassignment brings it to New Technology […]
